10 Year Financial Data of St Jude Medical, Inc. (STJ)

45.15 (1y: +14%)

Market Cap	12.78 B	P/E(ttm)	18.00
Enterprise Value	15.19 B	P/B	3.12

STJ- NYSE (USA)
St Jude Medical, Inc.

Currently 4/5

Business Predictability Rank: 4-Star
Back Testing Results:
Average gain of all 4-Star stocks: 9.8% per year.
% of Stocks that are in still loss if held for 10yrs: 8%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies

$45.15

1 Severe Warning Sign 5 Medium Warning Signs 1 Good Sign

Bookmark

Annual Rates (per share)	10 yrs*	5 yrs*	12 months*
Revenue Growth (%)	15	9.5	2.2
EBITDA Growth (%)	14.4	13.7	6.3
Free Cash Flow Growth (%)	12.8	21.8	8
Book Value Growth (%)	12.1	10.9	-6.3

*12-month growth rate is calculated with the per share revenue (EBITDA, FCF, earnings) of the last 12 months over the per share revenue (EBITDA, FCF, earnings) over the previous 12 months. 5-year and 10-year growth rates are calculated with least-square regression based on the 5-year and 10-year numbers.

Trendline:

Export:

Print This Table Print

See this page for the explanation of the data and charts * All numbers are in millions except for per share data

Per Share Data	Annuals											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	TTM	Mar12	Jun12	Sep12	Dec12	Mar13

Revenue per Share ($)	5.21	6.18	7.69	8.86	10.72	12.48	13.59	15.63	17.16	17.48	17.75	4.39	4.47	4.19	4.43	4.66
EBITDA per Share	1.44	1.68	1.96	2.44	2.81	2.45	3.85	4.60	4.31	4.40	4.54	1.17	1.30	0.97	0.96	1.31
Free Cashflow per Share	1.15	1.39	1.47	1.02	1.64	1.72	1.58	2.93	3.00	3.35	3.25	0.52	0.94	0.92	0.98	0.41
Earnings per Share ($)	0.92	1.10	1.04	1.47	1.59	1.10	2.26	2.75	2.52	2.39	2.51	0.67	0.78	0.56	0.39	0.78
Dividends Per Share	--	--	--	--	--	--	--	--	0.84	0.92	0.94	0.23	0.23	0.23	0.23	0.25
Book Value per Share	4.33	6.29	7.60	7.96	8.31	9.25	9.65	13.23	13.68	13.01	13.02	13.90	14.37	15.01	13.21	13.02
Month End Stock Price	30.68	41.93	50.20	36.56	40.64	32.96	36.78	42.75	34.30	36.14	40.44	44.31	39.91	42.13	36.14	40.44
Ratios	Annuals											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

Return on Equity %	21.20	17.60	13.60	18.50	19.10	11.90	23.40	20.80	18.50	18.40	24.00	19.20	21.60	14.80	11.60	24.00
Return on Assets %	13.30	12.70	8.10	11.40	10.50	6.70	12.10	10.60	9.20	8.10	9.60	9.20	10.80	8.00	5.20	9.60
Return on Capital - Joel Greenblatt %	54.60	59.80	51.60	47.90	42.40	33.20	43.00	45.60	39.60	43.40	45.20	41.60	47.20	33.20	35.60	45.20
Debt to Equity	0.23	0.10	0.37	0.29	0.47	0.37	0.58	0.58	0.63	0.75	0.90	0.68	0.65	0.53	0.75	0.90

Gross Margin %	68.80	70.40	72.70	72.30	72.40	73.20	73.20	72.70	72.70	72.10	71.80	72.70	72.80	73.20	69.50	71.80
Operating Margin %	23.60	23.40	21.00	22.50	21.00	15.00	23.80	24.70	19.90	20.00	23.00	21.60	24.00	17.70	16.40	23.00
Net Margin %	17.60	17.90	13.50	16.60	14.80	8.80	16.60	17.60	14.70	13.70	16.70	15.20	17.30	13.30	8.70	16.70

Days Sales Outstanding	94.80	100	99.40	97.50	98.90	92.10	91.30	94.10	88.90	89.50	89.70	92.50	87.10	92.60	89.50	89.70
Days Inventory	189	181	173	181	160	170	192	173	149	145	145	150	148	166	133	145
Inventory Turnover	1.90	2.00	2.10	2.00	2.30	2.10	1.90	2.10	2.50	2.50	0.60	0.60	0.60	0.50	0.70	0.60

Debt to Revenue	0.19	0.10	0.36	0.26	0.37	0.28	0.41	0.49	0.50	0.56	2.51	2.14	2.10	1.90	2.25	2.51
COGS to Revenue	0.31	0.29	0.27	0.28	0.28	0.27	0.27	0.27	0.27	0.28	0.28	0.27	0.27	0.27	0.31	0.28
Inventory to Revenue	0.16	0.14	0.13	0.14	0.12	0.13	0.14	0.13	0.11	0.11	0.45	0.45	0.44	0.49	0.45	0.45
Interest Exp. to Revenue %	--	--	--	-0.75	-0.90	-0.14	-0.93	-1.26	-1.17	-1.24	-1.35	-1.22	-1.28	-1.28	-1.17	-1.35

Asset Turnover	0.76	0.71	0.60	0.69	0.71	0.76	0.73	0.60	0.62	0.59	0.15	0.15	0.15	0.15	0.15	0.15
Buyback Ratio	-26.40	-35.70	-32.00	-14.10	-39.70	-43.20	--	--	--	--	--	--	--	--	--	--
Dividend Payout Ratio	--	--	--	--	--	--	--	--	0.33	0.39	0.32	0.35	0.30	0.41	0.59	0.32
Income Statement	Annuals (USD $) View: $ %											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	TTM	Mar12	Jun12	Sep12	Dec12	Mar13

Revenue	1,933	2,294	2,915	3,302	3,779	4,363	4,681	5,165	5,612	5,503	5,446	1,395	1,410	1,326	1,372	1,338
Cost of Goods Sold	603	667	797	914	1,042	1,171	1,253	1,410	1,532	1,538	1,534	381	383	355	419	377
Gross Profit	1,329	1,615	2,119	2,389	2,738	3,193	3,428	3,755	4,079	3,965	3,912	1,014	1,027	971	953	961

Selling, General, &Admin. Expense	632	759	969	1,195	1,382	1,637	1,675	1,818	2,085	1,891	1,869	490	494	456	451	468
Research &Development	241	282	369	431	476	532	560	631	709	676	661	175	173	170	158	160
Earnings Before DDA	533	622	743	910	991	857	1,327	1,521	1,410	1,384	1,388	372	409	306	297	376

Depreciation, Depletion and Amortization	76.68	85.76	130	167	198	202	213	244	296	284	282	70.00	71.00	71.00	72.00	68.00

Operating Income	456	536	613	743	794	655	1,113	1,277	1,114	1,100	1,106	302	338	235	225	308
Interest Income/Expense	--	--	--	-24.62	-33.86	-6.27	-43.55	-65.30	-65.41	-68.00	-69.00	-17.00	-18.00	-17.00	-16.00	-18.00
Net Income	339	410	393	548	559	384	777	907	826	752	763	212	244	176	120	223

Earnings per Share ($)	0.92	1.10	1.04	1.47	1.59	1.10	2.26	2.75	2.52	2.39	2.51	0.67	0.78	0.56	0.39	0.78
Total Shares Outstanding	371	371	379	373	352	350	344	330	327	315	287	318	315	316	310	287
Balance Sheet	Annuals (USD $) View: $ %											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

Cash and cash equivalents	461	688	535	79.89	389	136	393	500	986	1,194	966	1,053	1,214	1,051	1,194	966
Accounts Receivable	502	631	794	882	1,024	1,101	1,171	1,331	1,367	1,349	1,319	1,418	1,350	1,350	1,349	1,319
Inventory	312	331	378	453	458	546	660	668	624	610	602	626	621	648	610	602
Other Current Assets	218	213	234	275	257	296	337	413	413	398	458	422	402	388	398	458
Total Current Assets	1,492	1,863	1,941	1,690	2,128	2,080	2,560	2,912	3,391	3,551	3,345	3,519	3,587	3,437	3,551	3,345

Property, Plant and Equipment	302	327	438	618	777	980	1,153	1,324	1,388	1,425	1,438	1,413	1,413	1,409	1,425	1,438
Intangible Assets	561	801	2,207	2,210	2,156	2,478	2,462	3,943	3,809	3,765	3,886	3,806	3,767	3,747	3,765	3,886
Other Long Term Assets	201	240	258	272	268	184	251	388	417	530	491	438	419	426	530	491
Total Assets	2,556	3,231	4,845	4,790	5,329	5,723	6,426	8,566	9,005	9,271	9,160	9,176	9,186	9,019	9,271	9,160

Accounts Payable	426	504	549	555	627	935	733	938	576	763	664	566	919	978	763	664
Current Portion of Long-Term Debt	12.12	--	876	--	1,205	75.52	335	79.64	83.40	530	522	78.00	81.00	540	530	522
Other Current Liabilities	72.38	101	109	122	16.46	17.61	0.00	--	402	482	416	420	--	--	482	416
Total Current Liabilities	510	605	1,534	676	1,849	1,029	1,067	1,017	1,062	1,775	1,602	1,064	1,000	1,518	1,775	1,602

Long-Term Debt	352	235	177	859	182	1,126	1,588	2,432	2,713	2,550	2,833	2,908	2,882	1,983	2,550	2,833
Other Long-Term Liabilities	89.72	56.56	250	285	370	332	447	746	756	852	982	787	775	771	852	982
Total Liabilities	952	897	1,962	1,821	2,401	2,487	3,102	4,195	4,531	5,177	5,417	4,759	4,657	4,272	5,177	5,417

Common Stock	17.30	35.88	36.79	35.39	34.29	34.53	32.45	32.90	31.96	30.00	28.00	31.00	31.00	32.00	30.00	28.00
Retained Earnings	1,544	1,952	2,345	2,787	2,601	2,978	3,191	4,099	4,384	4,018	3,651	4,298	4,471	4,573	4,018	3,651
Additional Paid-In Capital	35.63	277	514	100	194	219	5.86	156	43.01	--	43.00	34.00	56.00	126	--	43.00
Total Equity	1,604	2,334	2,883	2,969	2,928	3,236	3,324	4,372	4,475	4,094	3,743	4,417	4,529	4,747	4,094	3,743
Cashflow Statement	Annuals (USD $) View: $ %											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	TTM	Mar12	Jun12	Sep12	Dec12	Mar13

Net Income	339	410	393	548	559	384	777	907	826	752	762	212	244	176	120	222
Depreciation, Depletion and Amortization	76.68	85.76	130	167	198	202	213	244	296	284	282	70.00	71.00	71.00	72.00	68.00
Cash Flow from Others	58.21	109	193	-66.25	109	359	-122	123	165	299	239	-47.00	39.00	103	204	-107
Cash Flow from Operations	474	604	716	649	866	946	869	1,274	1,287	1,335	1,283	235	354	350	396	183

Investment for Property, Plant & Equipement	-49.57	-89.47	-159	-268	-287	-344	-326	-305	-306	-280	-275	-70.00	-58.00	-60.00	-92.00	-65.00
Cash Flow from Acquisitions	-231	-250	-1,776	-38.80	-12.24	-490	-130	-679	--	--	--	--	--	--	--	--
Cash Flow from Investing	-347	-408	-1,811	-326	-306	-871	-491	-1,080	-337	-313	-319	-63.00	-78.00	-56.00	-116	-69.00

Net Issuance of Stock	-430	146	126	-623	-879	-134	-1,000	-591	-809	-992	-1,301	-300	--	--	-692	-609
Net Issuance of Debt	340	-135	842	-192	522	968	717	336	247	321	417	211	-37.00	-446	593	307
Cash Flow for Dividends	--	--	--	--	--	--	--	--	-205	-284	-285	-67.00	-72.00	-73.00	-72.00	-68.00
Other Financing	--	--	-0.00	28.58	97.92	-1,156	153	168	311	142	131	48.00	4.00	55.00	35.00	37.00
Cash Flow from Financing	-90.12	10.75	968	-786	-259	-322	-131	-86.55	-456	-813	-1,038	-108	-105	-464	-136	-333

Net Change in Cash	59.39	227	-153	-455	309	-253	256	107	485	208	-87.00	67.00	161	-163	143	-228

Free Cash Flow	425	515	558	381	578	602	542	969	980	1,055	1,008	165	296	290	304	118
Valuation Ratios (Daily)	Annuals											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

PE Ratio(ttm)
Price to Tangible Book
Price-to-Free-Cash-Flow ratio
PS Ratio
EV-to-Revenue
EV-to-EBITDA
EV-to-EBIT
Earnings Yield (Joel Greenblatt)
Forward Rate of Return
Shiller PE Ratio
Valuation and Quality	Annuals											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

Market Cap
Enterprise Value
Month End Stock Price
Net Cash (per share)
Net Current Asset Value (per share)
DCF (per share)
Median PS (per share)
Peter Lynch Fair Value (per share)
Graham Number (per share)
Altman Z-Score
Piotroski F-Score
Beneish M-Score

Switch to Another Stock:

STJ Quarterly/Annuals Reports

STJ: 10-Q - ST JUDE MEDICAL INC (0000203077) (Filer): (10-Q) - 2012-11-07
STJ: 10-Q - ST JUDE MEDICAL INC (0000203077) (Filer): (10-Q) - 2012-08-07
STJ: 10-Q - ST JUDE MEDICAL INC (0000203077) (Filer): (10-Q) - 2012-05-03
STJ: 10-K - ST JUDE MEDICAL INC (0000203077) (Filer): (10-K) - 2012-02-29
STJ: 10-Q - ST JUDE MEDICAL INC (0000203077) (Filer): (10-Q) - 2011-08-10

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names

Home About Jobs Advertise Site Map Term of Use Privacy Policy RSS Email Alerts Affiliate Program FAQ Contact Us
Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.

FocusBar

Home

Premium Membership

Value Screens

Model Portfolios

Guru Stocks

Market Valuation

By Country

Articles

Submit Articles

STJ Quarterly/Annuals Reports